MedTrace Logo

Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge

NCT03139097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2018-04-05

No results posted yet for this study

Summary

This study will establish reference range intervals for the Quantra System, a next-generation diagnostic platform that provides whole blood coagulation testing at the point-of-care.

Conditions

  • Coagulation

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Principal Investigators

  • Julia Warren-Ulanch, MD · Creedmoor Centre Endocrinology

  • Charles Greenberg, MD · Medical University of South Carolina

  • Kenichi Tanaka, MD · University of Maryland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2017-09-28
Completion
2017-09-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139097 on ClinicalTrials.gov